Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00802932 · ClinicalTrials.gov registry record

Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx

A clinical trial, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Completed
Registry status
61
Enrollment target

NCT00802932: Completed study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

NCT00802932 is a clinical trial that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00802932 has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

COMPLETED
Registry status
61 participants
Enrollment target

Study Summary

The purpose of this study is to test metallic markers in the breast tissue after breast conserving surgery and to observe the metallic markers' stability in the breast for use as tumor bed markers and positioning devices for radiation treatment.

Primary Outcome

To validate that intraparenchymal metallic markers placed in the breast tissue can be used as stable markers throughout a course of radiation treatment for daily image guided localization. Image Guided Radiation Therapy (IGRT) will be deemed feasible if the average shift in marker position results in deviations of up to 7 mm from the initial position.

Interventions

  • DEVICE Non-contrast Computed Tomography (CT) Scans (Metallic Markers)
  • DEVICE Non-contrast CT Scans (Metallic Markers)

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2008-03
Est. Completion 2012-10

What the finished NCT00802932 record still lists

NCT00802932 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target.

The record links to 0 conditions, and to 2 interventions - of which Non-contrast Computed Tomography (CT) Scans (Metallic Markers) is the first listed.

NCT00802932 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00802932 about?

NCT00802932 is a clinical study titled "Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx". The purpose of this study is to test metallic markers in the breast tissue after breast conserving surgery and to observe the metallic markers' stability in the breast for use as tumor bed markers and positioning devices for radiation treatment.

What is the current status of trial NCT00802932?

This trial is currently completed. The enrollment target is 61 participants. The study started on 2008-03. Estimated completion is 2012-10.

What interventions are being tested in trial NCT00802932?

The interventions under investigation include: Non-contrast Computed Tomography (CT) Scans (Metallic Markers) (DEVICE), Non-contrast CT Scans (Metallic Markers) (DEVICE).

Who is sponsoring clinical trial NCT00802932?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04115306 · 61 participants · Phase 1

    Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

  • NCT05070845 · 61 participants · Phase 2

    Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

  • NCT05187832 · 61 participants · Phase 1

    A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

  • NCT05269316 · 61 participants · Phase 1

    Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00802932, the US trial registry maintained by the National Library of Medicine. NCT00802932 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.